Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients

Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients

Background: Patients with heart failure were affected severely by COVID-19. Most heart failure patients are on guideline directed medical therapy, which includes ACE inhibitors (ACEI) and ARBs. These medications were controversial at the beginning of the pandemic due to their interplay with the rece...

Full description

Bibliographic Details
Main Authors: Wissam Mekary, Souha Fares, Farah Abdulhai, Gaelle Massoud, Marwan Refaat, Mathias Mericskay, George W. Booz, Fouad A. Zouein
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Heliyon
Subjects:
SARS-CoV-2
Renin angiotensin aldosterone system
Cardiac biomarkers
Inflammatory biomarkers
Inflammation
Cytokines
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023065817

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023065817

Similar Items